Acumen Pharmaceuticals, Inc. (ABOS) Tops Q1 EPS by 3c

Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) reported Q1 EPS of ($0.48), $0.03 better than the analyst estimate of ($0.51).

For earnings history and earnings-related data on Acumen Pharmaceuticals, Inc. (ABOS) click here.

You May Also Be Interested In

• Is Treasury selloff a major issue for stock market bulls?
• Kanye West to perform in Russia’s St Petersburg in October
• Brean Capital Upgrades Columbia Financial Inc (CLBK) to Buy